title-engageo 1060x254


What is ENGAGe?

Established in 2012, the European Network of Gynaecological Cancer Advocacy Groups is a network of European patient advocacy groups established by ESGO representing all gynaecological cancers particularly (ovary, endometrial, cervix, vulva and rare cancers).

Why is ENGAGe needed?

  • There are wide variations in patient care across Europe
  • Patients are not adequately informed about gynaecological cancer and their management
  • Survivorship issues are not adequately addressed and psychosocial support in general is poor

The ENGAGe objectives are to:

  • Facilitate the development of national gynaecological cancer patient groups in Europe and to facilitate networking and collaboration between them.
  • Disseminate information and share best practices to empower patient groups and improve the quality of care across Europe.
  • To increase patient representation in ESGO activities by education on current research and health policy.
  • To advocate patient care policies practices and access to appropriate care at both national and European levels.
  • To educate patient groups, health professionals, the public and health decision makers.


  • Health Practitioners
  • Women's health networks
  • Patient Groups
  • Cancer Organisations

Key trends

  • multidisciplinary input to treatment plans
  • centralisation of specialist care
  • individualization of treatment
  • community care in local environment
  • survivorship (>1 year)

Active areas of research

  • Early diagnosis – primary care/community
  • Targeted therapy
  • Familial risk
  • Selection of subgroups likely to benefit from individualized treatment
  • Quality of Life

Why ESGO is the natural partner of patient networks

  • The size of membership and meeting attendance reflect its global influence to ensure the gynaecological cancer patient perspective becomes integrated in the European cancer voice.
  • Raise attention to the need for further research and improve access to quality treatment and care.
  • No vested interests other than patient health makes it ideally placed to influence governments.
  • Provides a comprehensive approach to the health of women with gynaecological cancer.
  • Prospect of private/public partnership funding e.g. FP7, Horizon 2020.


You May Also Like


Patient Seminar

Vienna, 2017

Read More


Raise Awareness

Cancer Fact Sheets

Read More


Advocacy Toolkit

Designed For you! 

Read More


Patient Stories


Read More